Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) ROCE % : -0.22% (As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Chunghwa Chemical Synthesis & Biotech Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Chunghwa Chemical Synthesis & Biotech Co's annualized ROCE % for the quarter that ended in Dec. 2024 was -0.22%.

Chunghwa Chemical Synthesis & Biotech Co ROCE % Historical Data

The historical data trend for Chunghwa Chemical Synthesis & Biotech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chunghwa Chemical Synthesis & Biotech Co ROCE % Chart

Chunghwa Chemical Synthesis & Biotech Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

23.36

15.43

15.41

8.51

1.81

Chunghwa Chemical Synthesis & Biotech Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															5.14	4.74	3.31	-0.63	-0.22

Chunghwa Chemical Synthesis & Biotech Co ROCE % Calculation

Chunghwa Chemical Synthesis & Biotech Co's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	78.507	/	( ( (5171.651 - 831.412)	+	(4762.738 - 425.288) )	/ 2 )
	=	78.507	/	( (4340.239	+	4337.45)	/ 2 )
	=	78.507	/	4338.8445
	=	1.81 %

Chunghwa Chemical Synthesis & Biotech Co's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	-9.356	/	( ( (4866.909 - 549.25)	+	(4762.738 - 425.288) )	/ 2 )
	=	-9.356	/	( ( 4317.659	+	4337.45 )	/ 2 )
	=	-9.356	/	4327.5545
	=	-0.22 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Chunghwa Chemical Synthesis & Biotech Co ROCE % Related Terms

Thank you for viewing the detailed overview of Chunghwa Chemical Synthesis & Biotech Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Chunghwa Chemical Synthesis & Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chunghwa Chemical Synthesis & Biotech Co Ltd (TPE:1762) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Dongxing Street, Shulin District, Taipei, TWN

Website

http://www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co Ltd is engaged in the research, development, manufacturing, and sales of pharmaceutical products. Geographically, it derives a majority of its revenue from the United States and also has a presence in Taiwan. Its product portfolio comprises pain management, antifungal, immunosuppressant, oncology, Cardiovascular, Peptide Drugs, and Others.

Chunghwa Chemical Synthesis & Biotech Co Headlines

No Headlines